APExBIO - MJN110 | MAGL inhibitor | CAS# 1438416-21-7
Molecules | Free Full-Text | Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases
Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors | Acta Pharmacologica Sinica
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect
Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis: Cell
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice - eBioMedicine
A) Representative examples of covalent MAGL inhibitors with the... | Download Scientific Diagram
Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future Antidepressants | Bentham Science
Monoacylglycerol lipase (MAGL) as a promising therapeutic target - ScienceDirect
Chemical structures of representative urea-based MAGL inhibitors 22e27... | Download Scientific Diagram
Structures of representative urea-based MAGL inhibitors and H... | Download Scientific Diagram
Monoacylglycerol lipase - Wikipedia
Structural modifications of MAGL inhibitor 144. | Download Scientific Diagram
Molecules | Free Full-Text | Targeting Monoacylglycerol Lipase in Pursuit of Therapies for Neurological and Neurodegenerative Diseases
MJN110 is an Orally Active and Selective Monoacylglycerol Lipase Inhibitor - Immune System Research
Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors | Acta Pharmacologica Sinica
MAGL-IN-4 | MAGL Inhibitor | MedChemExpress
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect
MAGL Inhibitor Compound 23 (CAS Number: 2324160-91-8) | Cayman Chemical
Monoacylglycerol Lipase Inhibitor 21 (MAGL Inhibitor 21, MGL Inhibitor 21, CAS Number: 1643657-35-5) | Cayman Chemical
MAGL Inhibitor III, JZL184 - CAS 1101854-58-3 - Calbiochem | 475741
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice - eBioMedicine
Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders - ScienceDirect
